search
Back to results

Moderate or Extensive Carbohydrate Reduction in Risk Patients (LOWinCHIP)

Primary Purpose

Glucose Metabolism Disorders

Status
Unknown status
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Diet regime
Type of psychological support
Sponsored by
University Hospital, Linkoeping
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Glucose Metabolism Disorders

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diabetes without insulin. Patients at high risk for developing diabetes.

Exclusion Criteria:

  • Severe kidney failure. Insulin therapy. Inability to understand instructions.

Sites / Locations

  • University Hospital of LinkopingRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Arm Label

Moderate carbohydrate restriction and traditional support

Extreme low carbohydrate diet and traditional support

Moderate carbohydrate restriction and ACT support

Extreme carbohydrate restriction and ACT support

Arm Description

Moderate carbohydrate restriction and traditional support with group meetings

Extreme carbohydrate restriction and traditional support with group meetings

Moderate carbohydrate restriction and psychological support based on acceptance and commitment therapy

Extreme carbohydrate restriction and psychological support based on acceptance and commitment therapy

Outcomes

Primary Outcome Measures

Long-term glucose levels
HbA1c levels

Secondary Outcome Measures

Quality of Life
Quality of Life by questionnaires
Cardiovascular risk factors
Lipids, body weight, glucose, ketones

Full Information

First Posted
March 20, 2017
Last Updated
October 14, 2019
Sponsor
University Hospital, Linkoeping
search

1. Study Identification

Unique Protocol Identification Number
NCT03090074
Brief Title
Moderate or Extensive Carbohydrate Reduction in Risk Patients
Acronym
LOWinCHIP
Official Title
To Lower Glucose Levels and Reduce Weight by Exclusion of Carbohydrates and Inclusion of Psychological Behavioral Support
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Unknown status
Study Start Date
March 20, 2017 (Actual)
Primary Completion Date
March 19, 2021 (Anticipated)
Study Completion Date
March 19, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Linkoeping

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Risk-patients for diabetes or patients that are diagnosed with this condition but who are not treated with insulin are randomized two times, according to diet and according to the type of support: Randomization with regard to carbohydrate restriction (25-30 E% or < 10E%). Randomization with regard to type of psychological support. Either according to Acceptance and Commitment Therapy or to traditional cognitive behavioral therapy. Both kinds of psychological support is given as group therapy. Two-hundred patients are recruited and each patient is followed for two years.
Detailed Description
The organizers will recruit 200 patients in the study "To lower glucose levels and reduce weight by exclusion of carbohydrates and inclusion of psychological behavioral support" (LOWinCHIP) at the primary care health center "Cithyhälsan Centrum" in Norrköping. Each patient will be followed for 2 years. Patients are eligible if they have are above 18 years of age and have a BMI above 28 kg/m2 and also belong to one or more of the following groups: 1) type 2 diabetes that is not treated with insulin. 2) Patients that have had gestational diabetes or who have 3) first grade relative with type 2 diabetes. Finally 4) pre-diabetic individuals with impaired fasting glucose (6.1-6.9 mmol) or impaired glucose tolerance (capillary plasma glucose 8.9-12-1 after glucose challenge) are also potential participants. Patients must not have insulin therapy or severe kidney failure (GFR< 30). They can also not have severe physical restrictions for activity and they must not have difficulties with understanding written Swedish texts. The participants are randomized two times (two by two factorial): Randomization with regard to carbohydrate restriction (25-30 E% or < 10E%). Randomization with regard to type of psychological support. Either according to Acceptance and Commitment Therapy (ACT) or to traditional cognitive behavioral therapy. Each group will have three group sessions with approximately 8 participants followed by a telephone call by the therapist. Each session will be held by the psychologists that are part of the Cityhälsan Centrum staff. The study has > 95% power to demonstrate 5% HbA1c (mmol/mol) difference between groups with a drop out of 25%.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Glucose Metabolism Disorders

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Moderate carbohydrate restriction and traditional support
Arm Type
Active Comparator
Arm Description
Moderate carbohydrate restriction and traditional support with group meetings
Arm Title
Extreme low carbohydrate diet and traditional support
Arm Type
Active Comparator
Arm Description
Extreme carbohydrate restriction and traditional support with group meetings
Arm Title
Moderate carbohydrate restriction and ACT support
Arm Type
Active Comparator
Arm Description
Moderate carbohydrate restriction and psychological support based on acceptance and commitment therapy
Arm Title
Extreme carbohydrate restriction and ACT support
Arm Type
Active Comparator
Arm Description
Extreme carbohydrate restriction and psychological support based on acceptance and commitment therapy
Intervention Type
Behavioral
Intervention Name(s)
Diet regime
Intervention Description
Randomization to moderate or extreme low-carbohydrate Mediterranean diet advice.
Intervention Type
Behavioral
Intervention Name(s)
Type of psychological support
Intervention Description
Randomization to group-based psychological support according to ACT or to traditional cognitive behavioral therapy
Primary Outcome Measure Information:
Title
Long-term glucose levels
Description
HbA1c levels
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Quality of Life
Description
Quality of Life by questionnaires
Time Frame
2 years
Title
Cardiovascular risk factors
Description
Lipids, body weight, glucose, ketones
Time Frame
2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diabetes without insulin. Patients at high risk for developing diabetes. Exclusion Criteria: Severe kidney failure. Insulin therapy. Inability to understand instructions.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Fredrik H Nystrom, professor
Phone
736569303
Ext
+46
Email
fredrik.h.nystrom@gmail.com
Facility Information:
Facility Name
University Hospital of Linkoping
City
Linkoping
ZIP/Postal Code
58185
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fredrik H Nystrom, MD, prof.
First Name & Middle Initial & Last Name & Degree
Fredrik H Nystrom, MD PhD prof

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
It is not planned to be shared

Learn more about this trial

Moderate or Extensive Carbohydrate Reduction in Risk Patients

We'll reach out to this number within 24 hrs